Browse our collection of papers in
Pharmaceutical Industry

C/F/560. Strategic Financial Analysis of AstraZeneca and GlaxoSmithKline

WORDS:
3100
DATE:
2009
PRICE:
39.99 GBP

The paper examines the factors that affected the financial performance of AstraZeneca (AZN) and GlaxoSmithKline (GSK) giving particular focus to the analysis of the product portfolio and recent developments in the pharmaceutical industry. An overview of the companies’ ratios over 2004-2008 is provided suggesting recommendations for the investors.

 

KEYWORDS: GlaxoSmithKline, GSK, AstraZeneca, AZN, pharmaceutical industry,

 
Other Papers On: Astrazeneca (AZN)
Other Papers On: GlaxoSmithKline (GSK)
Other Papers On: Financial Analysis
Other Papers On: Pharmaceutical Industry